Long-term lamivudine monotherapy (LAM) in patients with HBeAg-negative HBV related chronic liver disease [HBeAg(−)CLD]: predictors of virological (VBTs) and biochemical (BBTs) breakthroughs

✍ Scribed by George Papatheodoridis; Evangelini Dimou; Andreas Laras; Vasilios Papadimitropoulos; Stephanos Hadziyannis

• Book ID: 118565788
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 222 KB
• Volume: 36
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(02)80872-8